No photo of Caroline L Ng

Caroline L Ng, PhD

  • Phone402-552-3035
  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
20032021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

David A. Fidock

  • Department of Microbiology and Immunology
  • Division of Infectious Diseases
  • Columbia University
  • Department of Microbiology and Immunology
  • Division of Molecular Medicine
  • New York University
  • Department of Medicine

External person

Sergio Wittlin

  • Swiss Tropical Institute
  • University of Basel
  • Swiss Tropical and Public Health Institute
  • University of Basel
  • Department of Medical Parasitology and Infection Biology

External person

Margaret A. Phillips

  • University of Texas Southwestern Medical Center at Dallas
  • Southwestern Medical Center
  • Univ. Texas Southwestern Med. Ctr.
  • University of Texas Southwestern Medical Center
  • Department of Pharmacology
  • Department of Biochemistry
  • Department of Biochemistry

External person

Elizabeth A. Winzeler

  • University of California at San Diego
  • Department of Pediatrics
  • Department of Pediatrics

External person

Michael Delves

  • Imperial College London
  • Department of Life Sciences

External person

Robert Sinden

  • Imperial College London
  • Department of Life Sciences

External person

Andrea Ruecker

  • Imperial College London
  • Department of Life Sciences
  • University of Oxford
  • Mahidol University

External person

Thomas Rückle

  • GeNeuro SA
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Marcus C.S. Lee

  • Malaria Programme
  • Department of Microbiology and Immunology
  • Columbia University
  • Wellcome Trust
  • Wellcome Sanger Institute
  • Malaria Programme
  • Parasites and Microbes Programme
  • Department of Microbiology and Immunology
  • New York University

External person

Jörg J. Möhrle

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Matthew Bogyo

  • Stanford University
  • Department of Microbiology and Immunology
  • Department of Pathology

External person

Julie Lotharius

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Koen Dechering

  • TropIQ Health Sciences

External person

Arpan Acharya

  • Department of Pharmacology and Experimental Neuroscience
  • University of Nebraska Medical Center

External person

Didier Leroy

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Nathalie Gobeau

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Vicky M. Avery

  • Griffith University Queensland
  • Discovery Biology

External person

Iñigo Angulo-Barturen

  • GlaxoSmithKline
  • Tres Cantos Medicines Development Campus
  • GlaxoSmithKline (GSK)
  • TresCantos Medicines Development Campus
  • Tres Cantos Medicines Development Campus

External person

Melissa R. Rosenthal

  • University of Nebraska Medical Center
  • University of Nebraska Omaha

External person

Maria Lafuente-Monasterio

  • GlaxoSmithKline (GSK)
  • GlaxoSmithKline
  • TresCantos Medicines Development Campus

External person

Martine Clozel

  • Department of Drug Discovery
  • Actelion Pharmaceuticals Ltd.

External person

Kristina Oresic

  • Icahn School of Medicine at Mount Sinai
  • Department of Microbiology
  • One Gustave L. Levy Place

External person

Ralf Brunner

  • Actelion Pharmaceuticals Ltd.
  • University of Basel
  • Swiss Tropical and Public Health Institute
  • Department of Medical Parasitology and Infection Biology

External person

Bibia Heidmann

  • Actelion Pharmaceuticals Ltd.
  • Drug Discovery Chemistry and Biology

External person

Christoph Binkert

  • Actelion Pharmaceuticals Ltd.
  • Drug Discovery Chemistry and Biology

External person

T. R.S. Kumar

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University
  • Department of Microbiology and Immunology

External person

James M. Murithi

  • Department of Microbiology and Immunology
  • Columbia University
  • Department of Microbiology and Immunology
  • New York University

External person

Amélie Le Bihan

  • Department of Drug Discovery
  • Actelion Pharmaceuticals Ltd.

External person

Domenico Tortorella

  • Icahn School of Medicine at Mount Sinai
  • Department of Microbiology
  • One Gustave L. Levy Place

External person

Sandra Duffy

  • Griffith University Queensland
  • Discovery Biology

External person

Reto Brun

  • University of Basel
  • Swiss Tropical and Public Health Institute
  • Department of Medical Parasitology and Infection Biology

External person

Laura María Sanz

  • TresCantos Medicines Development Campus
  • GlaxoSmithKline

External person

Xiaoyi Deng

  • University of Texas Southwestern Medical Center
  • Department of Pharmacology
  • Department of Biochemistry
  • Department of Biochemistry

External person

Giulia Siciliano

  • Dipartimento di Malattie Infettive
  • Istituto Superiore di Sanita

External person

Santiago Ferrer

  • GlaxoSmithKline
  • Tres Cantos Medicines Development Campus
  • TresCantos Medicines Development Campus
  • Tres Cantos Medicines Development Campus

External person

María B. Jiménez-Díaz

  • GlaxoSmithKline
  • Tres Cantos Medicines Development Campus
  • GlaxoSmithKline (GSK)
  • TresCantos Medicines Development Campus
  • Tres Cantos Medicines Development Campus

External person

Maria Rosario

  • Takeda Development Center Americas Inc

External person

Farah El Mazouni

  • University of Texas Southwestern Medical Center
  • Department of Pharmacology
  • Department of Biochemistry
  • Department of Biochemistry

External person

Euna Yoo

  • Stanford University

External person

Victoria C. Corey

  • University of California at San Diego
  • Department of Pediatrics

External person

Barbara H. Stokes

  • Department of Microbiology and Immunology
  • Columbia University
  • Department of Microbiology and Immunology

External person

Diana R. Tomchick

  • University of Texas Southwestern Medical Center
  • Department of Biophysics
  • Department of Biophysics
  • University of Texas at Dallas

External person

María S. Martinez

  • GlaxoSmithKline
  • Tres Cantos Medicines Development Campus
  • GlaxoSmithKline (GSK)
  • TresCantos Medicines Development Campus
  • Tres Cantos Medicines Development Campus

External person

Pietro Alano

  • Dipartimento di Malattie Infettive
  • Istituto Superiore di Sanita

External person

Robert W. Sauerwein

  • Radboud University Nijmegen
  • Department of Medical Microbiology
  • TropIQ Health Sciences
  • Department of Medical Microbiology

External person

Christoph Boss

  • Actelion Pharmaceuticals Ltd.
  • Drug Discovery Chemistry and Biology

External person

Manu Vanaerschot

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University
  • Department of Microbiology and Immunology

External person

Jade Bath

  • Department of Microbiology and Immunology
  • Columbia University
  • Department of Microbiology and Immunology
  • New York University

External person

Pradipsinh K. Rathod

  • University of Washington
  • Department of Chemistry
  • Departments of Chemistry and Global Health

External person

Jeremy N. Burrows

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Nina Lawrence

  • Drug Discovery and Development Centre (H3D)
  • University of Cape Town

External person

Leonardo Lucantoni

  • Discovery Biology
  • Griffith University Queensland

External person

Tessa M. Firestone

  • University of Nebraska Medical Center

External person

Stephen Toovey

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Janet Gahagen

  • SRI International

External person

Amélie Le Bihan

  • Drug Discovery Chemistry and Biology
  • Actelion Pharmaceuticals Ltd.

External person

Arun Sridhar

  • GSK
  • GlaxoSmithKline

External person

Ian Bathhurst

  • Medicines for Malaria Venture

External person

Christian Scheurer

  • University of Basel
  • Swiss Tropical Institute
  • University of Basel
  • Swiss Tropical and Public Health Institute

External person

Ingrid B. Müller

  • Bernhard Nocht Institute for Tropical Medicine

External person

Laura Maria Sanz Alonso

  • GlaxoSmithKline (GSK)
  • GlaxoSmithKline

External person

Romain Siegrist

  • Drug Discovery Chemistry and Biology
  • Actelion Pharmaceuticals Ltd.

External person

Manuel Llinás

  • Department of Molecular Biology and Lewis
  • Princeton University
  • Department of Biochemistry and Molecular Biology
  • Pennsylvania State University

External person

Josh Sharp

  • Icahn School of Medicine at Mount Sinai
  • Department of Pharmacology and Biological Chemistry

External person

Jenny Legac

  • University of California at San Francisco
  • Department of Medicine

External person

Sarah Schleiferboeck

  • University of Basel
  • Swiss Tropical and Public Health Institute

External person

Paul D. Roepe

  • Department of Chemistry, Biochemistry, and Cellular and Molecular Biology
  • Georgetown University

External person

Philipp P. Henrich

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Daniel Scanfeld

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Christoph Fischli

  • University of Basel
  • Swiss Tropical and Public Health Institute

External person

Felix D. Rozenberg

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Myles H. Akabas

  • Department of Physiology and Biophysics
  • Yeshiva University

External person

Magdia De Jesus

  • Icahn School of Medicine at Mount Sinai
  • Department of Pharmacology and Biological Chemistry

External person

Arnold Garcia

  • University of California at San Diego

External person

Ruben de Kanter

  • Actelion Pharmaceuticals Ltd.

External person

Joseph L. Derisi

  • University of California at San Francisco
  • Department of Medicine
  • Department of Biochemistry and Biophysics
  • Department of Biochemistry and Biophysics

External person

Karen L. White

  • Monash University
  • Centre for Drug Candidate Optimisation
  • Centre for Drug Candidate Optimisation

External person

Mathew Njoroge

  • Drug Discovery and Development Centre (H3D)
  • University of Cape Town

External person

Susan A. Charman

  • Monash University
  • Monash University (Parkville Campus)
  • Monash Institute of Pharmaceutical Sciences
  • Centre for Drug Candidate Optimisation
  • Centre for Drug Candidate Optimisation
  • Centre for Drug Candidate Optimisation

External person

Yong Kang Zhang

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Stephan Chalon

  • Medicines for Malaria Venture

External person

M. R.K. Alley

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Jill M. Combrinck

  • Division of Pharmacology
  • University of Cape Town

External person

John White

  • University of Washington

External person

Terry A. Krulwich

  • Mt. Sinai School of Medicine
  • Mount Sinai School of Medicine
  • Icahn School of Medicine at Mount Sinai
  • Department of Pharmacology and Systems Therapeutics
  • Department of Pharmacology and Biological Chemistry

External person

Paul Jenö

  • Proteomics Core Facility
  • University of Basel

External person

Olivier Lichtarge

  • Computational and Integrative Biomedical Research Center
  • Verna and Marrs McLean Department of Biochemistry
  • Department of Pharmacology
  • Baylor College of Medicine
  • Department of Molecular and Human Genetics

External person

Nicola Kerr

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Andreas Martin Lisewski

  • Computational and Integrative Biomedical Research Center
  • Baylor College of Medicine
  • Department of Molecular and Human Genetics

External person

Kim Lee Sim

  • Sanaria Inc.
  • Sanaria Inc

External person

Trevor Laird

  • Medicines for Malaria Venture

External person

Jeremiah D. Momper

  • University of California at San Diego

External person

Yvonne R. Freund

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Sreekanth Kokkonda

  • Departments of Chemistry and Global Health
  • University of Washington

External person

Pedro E. Ferreira

  • University of Minho

External person

Annie N. Cowell

  • University of California at San Diego

External person

Madeline R. Luth

  • University of California at San Diego
  • Department of Pediatrics

External person

Jie Jin

  • Division of Hematology
  • Icahn School of Medicine at Mount Sinai
  • Harvard University
  • Department of Pharmacology and Biological Chemistry

External person

Timothy J. Egan

  • University of Cape Town
  • Department of Chemistry

External person

Nina F. Gnädig

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Suzette Moes

  • Proteomics Core Facility
  • University of Basel

External person

Ric N. Price

  • Global and Tropical Health Division
  • University of Oxford
  • Charles Darwin University

External person

Ebere Sonoiki

  • University of California at Berkeley
  • School of Public Health
  • University of California at San Francisco
  • Department of Medicine

External person

Francisco Javier Gamo Benito

  • GlaxoSmithKline (GSK)
  • GlaxoSmithKline

External person

Aloysus Lawong

  • Department of Biochemistry
  • University of Texas Southwestern Medical Center
  • Department of Biochemistry

External person

Thomas Weller

  • Actelion Pharmaceuticals Ltd.

External person

Raúl Chuquiyauri

  • Asociación Civil Selva Amazónica
  • Universidad Peruana Cayetano Heredia
  • Asociación Civil Selva Amazónica

External person

Sam J. Regenbogen

  • Department of Pharmacology
  • Baylor College of Medicine

External person

Robert H. Arch

  • Takeda Development Center Americas Inc

External person

Michelle Paguio

  • Department of Chemistry, Biochemistry, and Cellular and Molecular Biology
  • Georgetown University

External person

Paula C.A. da Fonseca

  • Medical Research Council
  • MRC Laboratory of Molecular Biology

External person

Sandra March

  • Institute for Medical Engineering and Science
  • Massachusetts Institute of Technology

External person

Nicole Andenmatten

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Solange Meyer

  • Actelion Pharmaceuticals Ltd.

External person

Opeoluwa O. Oyewole

  • University of Nebraska Medical Center

External person

Heather Griffith

  • Skirball Inst. of Biomol. Medicine
  • New York University

External person

Xavier Ding

  • Medicines for Malaria Venture

External person

Rintis Noviyanti

  • Eijkman Institute for Molecular Biology

External person

Richard T. Eastman

  • Department of Microbiology and Immunology
  • Columbia University
  • National Institutes of Health
  • Laboratory of Malaria and Vector Research
  • New York University

External person

Ithiel J. Frame

  • Department of Physiology and Biophysics
  • Yeshiva University

External person

M. Isabel Veiga

  • University of Minho

External person

Francisco Javier Gamo

  • GlaxoSmithKline
  • TresCantos Medicines Development Campus

External person

Selina E. Bopp

  • Harvard University
  • Department of Immunology and Infectious Diseases
  • University of California at San Diego
  • Department of Pediatrics

External person

Clemens Kocken

  • Biomedical Primate Research Centre

External person

Renier Van Der Westhuyzen

  • Drug Discovery and Development Centre (H3D)
  • University of Cape Town

External person

Suzanne Elliott

  • Q-Pharm Pty Ltd

External person

Kazutoyo Miura

  • National Institutes of Health
  • Laboratory of Malaria and Vector Research

External person

Grennady Wirjanata

  • Global and Tropical Health Division
  • Charles Darwin University

External person

Kabita Pandey

  • University of Nebraska Medical Center

External person

Philip J. Rosenthal

  • University of California at San Francisco
  • Department of Medicine
  • Department of Surgery
  • Department of Pediatrics
  • University of Southern California
  • University of Milan
  • University of Nebraska Medical Center
  • Department of Pediatrics
  • Department of Pharmaceutical Chemistry
  • Div. Pediat. Gastroenterol. Nutr.
  • Department of Biomathematics
  • Division of Pediatric Gastroenterology and Nutrition
  • University of California at Los Angeles
  • Rosalind Russell Medical Research Center for Arthritis
  • The EMMES Corporation
  • SPLIT Research Group
  • The EMMES Corporation
  • Div. of Pediat. Gastroenterol./Nutr.

External person

Jutta Marfurt

  • Global and Tropical Health Division
  • Charles Darwin University

External person

Anthony Dayan

  • Medicines for Malaria Venture

External person

Brice Campo

  • Medicines for Malaria Venture

External person

Hamed Aissaoui

  • Drug Discovery Chemistry and Biology
  • Actelion Pharmaceuticals Ltd.

External person

Rachel G. Kasdin

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Mark Baker

  • GlaxoSmithKline

External person

Christopher Snyder

  • University of Basel
  • Swiss Tropical Institute
  • University of Basel
  • Swiss Tropical and Public Health Institute
  • Actelion Pharmaceuticals Ltd.

External person

Paul Griffin

  • Q-Pharm Pty Ltd

External person

Lalitha Iyer

  • SRI International

External person

Markus Safferling

  • Skirball Inst. of Biomol. Medicine
  • Bayer CropScience
  • Icahn School of Medicine at Mount Sinai
  • Department of Pharmacology and Biological Chemistry
  • New York University
  • Bayer AG

External person

Corinna Mattheis

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

James S. McCarthy

  • Q-Pharm Pty Ltd
  • Queensland Institute of Medical Research

External person

Mariana J. de Almeida

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Juan Carlos Hinojosa

  • Asociación Civil Selva Amazónica

External person

Richard W.D. Welford

  • Actelion Pharmaceuticals Ltd.

External person

Kelly Rubiano

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Chen Dong

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Satish K. Dhingra

  • Department of Microbiology and Immunology
  • Columbia University
  • Department of Microbiology and Immunology

External person

Lidiya Bebrevska

  • Medicines for Malaria Venture

External person

Ori J. Lieberman

  • Columbia University

External person

Tao Li

  • Sanaria Inc.
  • Sanaria Inc

External person

Pavel Afanasyev

  • Medical Research Council

External person

Roland A. Cooper

  • Department of Natural Sciences and Mathematics
  • Dominican University of California

External person

Lucia Bertuccini

  • Istituto Superiore di Sanita

External person

Hanna De Jong

  • Stanford University

External person

Gustavo A. Afanador

  • Department of Biochemistry
  • University of Texas Southwestern Medical Center
  • Department of Biochemistry

External person

Lindsey Altenhofen

  • Department of Molecular Biology and Lewis
  • Princeton University
  • Department of Biochemistry and Molecular Biology
  • Pennsylvania State University

External person

Alejandro Llanos-Cuentas

  • Universidad Peruana Cayetano Heredia

External person

Nagireddy Putluri

  • Verna and Marrs McLean Department of Biochemistry
  • Baylor College of Medicine
  • Department of Molecular and Cellular Biology

External person

Noelle S. Williams

  • University of Texas Southwestern Medical Center

External person

Anbu Karani Adikesavan

  • Baylor College of Medicine
  • Department of Molecular and Human Genetics
  • Department of Molecular and Cellular Biology

External person

Sonia Gulati

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

James Louttit

  • GSK
  • GlaxoSmithKline

External person

Vida Ahyong

  • University of California at San Francisco
  • Department of Biochemistry and Biophysics

External person

Ed Riccio

  • SRI International

External person

Jiri Gut

  • University of California at San Francisco
  • Rosalind Russell Medical Research Center for Arthritis
  • Department of Medicine

External person

Jacqueline W. Njoroge

  • University of Texas Southwestern Medical Center
  • Department of Pharmacology

External person

Martin Casapia

  • Asociación Civil Selva Amazónica

External person

Stephan Duparc

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Francisco Javier Gamo–Benito

  • TresCantos Medicines Development Campus
  • GlaxoSmithKline

External person

Paul S. Callaghan

  • Department of Chemistry, Biochemistry, and Cellular and Molecular Biology
  • Georgetown University

External person

Stephan Buchmann

  • Actelion Pharmaceuticals Ltd.

External person

Patrick G. Schupp

  • Department of Microbiology and Immunology
  • Columbia University

External person

Yasheen Zhou

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Mahesh Mohan

  • Tulane University
  • Division of Comparative Pathology
  • Southwest Foundation for Biomedical Research

External person

Omalla A. Olwenyi

  • Department of Pathology and Microbiology
  • University of Nebraska Medical Center
  • Makerere University

External person

Sangeeta N. Bhatia

  • Broad Institute
  • Massachusetts Institute of Technology
  • Harvard University
  • Marble Center for Cancer Nanomedicine
  • Division of Medicine
  • Ludwig Center for Molecular Oncology
  • Department of Electrical Engineering and Computer Science
  • Institute for Medical Engineering and Science

External person

John N. Haselden

  • GlaxoSmithKline (GSK)
  • GlaxoSmithKline

External person

M. John Rogers

  • National Institutes for Allergy and Infectious Diseases

External person

Sonja Ewerling

  • Actelion Pharmaceuticals Ltd.

External person

Nada Araeipour

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Judith Straimer

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Kristina S. Wickham

  • SUNY Upstate Medical University

External person

Denghui Guo

  • University of California at San Francisco
  • Department of Medicine

External person

Rosemary Rochford

  • SUNY Upstate Medical University

External person

Jon Mirsalis

  • SRI International

External person

Till Voss

  • University of Basel
  • Swiss Tropical and Public Health Institute
  • Department of Medical Parasitology and Infection Biology

External person

Olivier Corminboeuf

  • Drug Discovery Chemistry and Biology
  • Actelion Pharmaceuticals Ltd.

External person

Da Neng Wang

  • Skirball Inst. of Biomol. Medicine
  • New York University

External person

Yi Cui

  • GSK
  • GlaxoSmithKline

External person

John White

  • Departments of Chemistry and Global Health
  • University of Washington

External person

Anna Marie Zeeman

  • Biomedical Primate Research Centre

External person

Carole Long

  • National Institutes of Health
  • Laboratory of Malaria and Vector Research

External person

Silvana Sekuloski

  • Queensland Institute of Medical Research

External person

Joel P. Quiros

  • Integrative Molecular and Biomedical Sciences Graduate Program
  • Baylor College of Medicine

External person

Louise Marquart

  • Queensland Institute of Medical Research

External person

Rob Hooft Van Huijsduijnen

  • Medicines for Malaria Venture (MMV)
  • Medicines for Malaria Venture

External person

Arun Sreekumar

  • Verna and Marrs McLean Department of Biochemistry
  • Department of Biochemistry and Molecular Biology
  • Baylor College of Medicine
  • Department of Molecular and Cellular Biology

External person

Walter Fischli

  • Actelion Pharmaceuticals Ltd.

External person

Stephen L. Hoffman

  • Sanaria Inc.
  • Sanaria Inc

External person

Your message has successfully been sent.
Your message was not sent due to an error.